EBA
MRNA icon

Eagle Bay Advisors’s Moderna MRNA Stock Holding History

Eagle Bay Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-33
Closed -$1.37K – 647
2024
Q4 		$1.37K Hold
33
– – ﹤0.01% 924
2024
Q3 		$2.21K Hold
33
– – ﹤0.01% 1206
2024
Q2 		$3.92K Hold
33
– – ﹤0.01% 770
2024
Q1 		$3.52K Hold
33
– – ﹤0.01% 802
2023
Q4 		$3.28K Hold
33
– – ﹤0.01% 696
2023
Q3 		$3.41K Sell
33
-13
-28% -$1.45K ﹤0.01% 714
2023
Q2 		$5.59K Hold
46
– – ﹤0.01% 656
2023
Q1 		$7.07K Hold
46
– – ﹤0.01% 630
2022
Q4 		$8.26K Sell
46
-327
-88% -$53.5K ﹤0.01% 628
2022
Q3 		$44K Buy
373
+93
+33% +$14.1K 0.03% 362
2022
Q2 		$40K Buy
+280
New +$40K 0.02% 416
2022
Q1 		– Sell
-108
Closed -$27K – 697
2021
Q4 		$27K Buy
108
+72
+200% +$21.1K 0.02% 510
2021
Q3 		$14K Buy
+36
New +$13.3K 0.01% 682

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eagle Bay Advisors's MRNA Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Moderna (MRNA) in Q1 2025, closing a stake of 33 shares — an estimated $1.37K sold.

Eagle Bay Advisors first reported a position in MRNA in Q3 2021 and held it in 13 quarters. The position peaked at $44K in Q3 2022. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 33 Moderna shares in Q1 2025, an estimated $1.37K.
  • Eagle Bay Advisors first reported a position in Moderna in Q3 2021 and held it in 13 quarters.
  • Eagle Bay Advisors's Moderna position peaked at $44K in Q3 2022.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.